Your browser doesn't support javascript.
loading
Anti-TCRß mAb in Combination With Neurogenin3 Gene Therapy Reverses Established Overt Type 1 Diabetes in Female NOD Mice.
Xie, Aini; Li, Rongying; Jiang, Tao; Yan, Hui; Zhang, Hedong; Yang, Yisheng; Yang, Lina; Yechoor, Vijay; Chan, Lawrence; Chen, Wenhao.
Afiliação
  • Xie A; Center for Immunobiology and Transplantation Research, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, Texas 77030.
  • Li R; Division of Diabetes, Endocrinology & Metabolism, Diabetes & Endocrinology Research Center, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030.
  • Jiang T; Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Yan H; Division of Diabetes, Endocrinology & Metabolism, Diabetes & Endocrinology Research Center, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030.
  • Zhang H; Center for Immunobiology and Transplantation Research, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, Texas 77030.
  • Yang Y; Center for Immunobiology and Transplantation Research, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, Texas 77030.
  • Yang L; Center for Immunobiology and Transplantation Research, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, Texas 77030.
  • Yechoor V; Division of Diabetes, Endocrinology & Metabolism, Diabetes & Endocrinology Research Center, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030.
  • Chan L; Division of Diabetes, Endocrinology & Metabolism, Diabetes & Endocrinology Research Center, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030.
  • Chen W; Division of Diabetes, Endocrinology & Metabolism, Diabetes & Endocrinology Research Center, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030.
Endocrinology ; 158(10): 3140-3151, 2017 10 01.
Article em En | MEDLINE | ID: mdl-28977608
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Receptores de Antígenos de Linfócitos T alfa-beta / Diabetes Mellitus Tipo 1 / Fatores de Transcrição Hélice-Alça-Hélice Básicos / Anticorpos Monoclonais / Proteínas do Tecido Nervoso Limite: Animals Idioma: En Revista: Endocrinology Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Receptores de Antígenos de Linfócitos T alfa-beta / Diabetes Mellitus Tipo 1 / Fatores de Transcrição Hélice-Alça-Hélice Básicos / Anticorpos Monoclonais / Proteínas do Tecido Nervoso Limite: Animals Idioma: En Revista: Endocrinology Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos